Pierce K. H. Chow

机构：SingHealth, Singapore General Hospital, Duke-NUS Medical School, National Cancer Centre Singapore · ORCID：0000-0003-0584-2584

发表论文 611 篇 · 总被引 27279 次 · h-index 87

代表论文

• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment (2025 · The Lancet · 被引 165)
• APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 (2024 · Hepatology International · 被引 59)
• The epigenetic basis of hepatocellular carcinoma – mechanisms and potential directions for biomarkers and therapeutics (2025 · British Journal of Cancer · 被引 53)
• Targeting Treg–fibroblast interaction to enhance immunotherapy in steatotic liver disease-related hepatocellular carcinoma (2025 · Gut · 被引 26)
• Inhibition of the Caveolin-1 pathway promotes apoptosis and overcomes pan-tyrosine kinase inhibitor resistance in hepatocellular carcinoma (2025 · Cell Death and Disease · 被引 12)
• Improving surgical treatments for hepatocellular carcinoma (2025 · Nature Reviews Gastroenterology & Hepatology · 被引 11)